about
Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot study.Regulatory T-cell heterogeneity and the cancer immune responseSafety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.β7 integrins contribute to intestinal tumor growth in mice
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Immune cell interplay in colorectal cancer prognosis
@ast
Immune cell interplay in colorectal cancer prognosis
@en
Immune cell interplay in colorectal cancer prognosis
@nl
type
label
Immune cell interplay in colorectal cancer prognosis
@ast
Immune cell interplay in colorectal cancer prognosis
@en
Immune cell interplay in colorectal cancer prognosis
@nl
prefLabel
Immune cell interplay in colorectal cancer prognosis
@ast
Immune cell interplay in colorectal cancer prognosis
@en
Immune cell interplay in colorectal cancer prognosis
@nl
P2093
P2860
P356
P1476
Immune cell interplay in colorectal cancer prognosis
@en
P2093
Edward S Taylor
Kirsten A Ward-Hartstonge
Roslyn A Kemp
Samuel E Norton
P2860
P304
P356
10.4251/WJGO.V7.I10.221
P407
P577
2015-10-15T00:00:00Z